Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neurostimulation in Pudendal Nerve Block

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03072329
Recruitment Status : Completed
First Posted : March 7, 2017
Last Update Posted : March 7, 2017
Sponsor:
Information provided by (Responsible Party):
Dr Sonia ben khalifa (PhD), Hôpital d'enfants Béchir-Hamza

Brief Summary:
The purpose of this study is to check whether the success rate of blind pudendal nerve block in penile surgery can be optimized by the search for a motor response during neurostimulation.

Condition or disease Intervention/treatment Phase
Penile Surgery Procedure: Pudendal nerve block Drug: Bupivacaine Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 150 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Neurostimulation in Pudendal Nerve Block: is That Really Necessary?
Study Start Date : October 2016
Actual Primary Completion Date : February 20, 2017
Actual Study Completion Date : March 1, 2017

Resource links provided by the National Library of Medicine

Drug Information available for: Bupivacaine

Arm Intervention/treatment
Experimental: Pudendal nerve block
Bilateral pudendal nerve block with the administration of 0.1 mL/kg Bupivacaïne 0.5%, regardless of neurostimulation response.
Procedure: Pudendal nerve block
Drug: Bupivacaine



Primary Outcome Measures :
  1. Nerve block success [ Time Frame: 15 minutes ]
    Nerve block success is defined by the absence of 20% increase in heart rate or systolic blood pressure baseline values



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Months and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Children scheduled for elective penile surgery (hypospadias / circumcision)

Non-inclusion Criteria:

  • Association to further peripheral nerve blocks required

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03072329


Locations
Layout table for location information
Tunisia
Hôpital d'Enfants Béchir Hamza
Bab Saadoun, Tunis, Tunisia, 1029
Sponsors and Collaborators
Hôpital d'enfants Béchir-Hamza
Investigators
Layout table for investigator information
Principal Investigator: Ben Khalifa Sonia, PhD

Layout table for additonal information
Responsible Party: Dr Sonia ben khalifa (PhD), Head of Anesthesia and Intensive Care Department, Hôpital d'enfants Béchir-Hamza
ClinicalTrials.gov Identifier: NCT03072329     History of Changes
Other Study ID Numbers: PNB-001
First Posted: March 7, 2017    Key Record Dates
Last Update Posted: March 7, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Bupivacaine
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents